Welcome to Coulter Partners Global (English)

20 April 2021

Top hires for VC & PE portfolio companies Q1-2021

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Oncology Switzerland
CEO Dental implants Benelux
CEO Cancer immunotherapies Germany
Chief Financial Officer Cell therapy US
Chief Operating Officer Veterinary services Sweden
Chief Medical Officer Immunotherapies Switzerland
Chief Business Officer Immuno-oncology Switzerland
Head of Commercial Excellence Medical devices Ireland
VP CMC RNA therapeutics US
VP Sales Drug delivery devices Switzerland
VP Medical Affairs Gene therapy US
Business Unit Head Life science tools UK
Digital Health Solutions Director Ophthalmology diagnostics France
Senior Director Program Management Vaccines US
Director of Biologics Antibody therapeutics UK
Board Director Regenerative therapeutic biologics UK
Board Director Surgical solutions US
Chair Rare diseases France
Partner Life science PE investor Belgium

Newly opened projects include:

Function Focus area Location
CEO CNS diseases Singapore
Chief Medical Officer Autoimmune disorders Italy
Chief Technology Officer Immuno-oncology US
Chief Product Officer Digital health UK
VP Clinical Development Personalised medicine Netherlands
VP HR Covalent therapeutics US
VP Operations Imaging technology Belgium
VP Global Business Development & Licensing Digital health Iceland
General Manager Laboratory Services Veterinary services UK
Quality & Regulatory Affairs Director A.I. enabled cardiac diagnostics US


A new version of Coulter Partners is available.